Skip to content

Randomised trial, 2007

Does bromocriptine or pyridoxine help reduce PMS symptoms?

Both bromocriptine and pyridoxine significantly reduced PMS symptoms over 3 months. Pyridoxine showed a higher response rate with fewer side effects.

Moderate study design 60 women aged 20-45 with PMS (20 per treatment group)

What they did

RCT comparing bromocriptine (2.5 mg twice daily), pyridoxine (100 mg/day), and placebo (ferrous sulphate 100 mg) in 60 women aged 20-45 with PMS. Women were followed monthly for 3 months and symptom scores were recorded before and after treatment.

What they found

The placebo group showed no significant change. Both bromocriptine and pyridoxine significantly reduced mean premenstrual symptom scores. Pyridoxine showed a significantly higher response rate and lower rate of side effects compared to bromocriptine.

What it means for you

Both drugs can reduce PMS symptoms, but pyridoxine appears safer and more effective. The main limit is the small sample size of 20 women per treatment group, so these results may not apply to larger or more diverse populations.

60

women total

3

months of treatment

100 mg/day

pyridoxine dose

About the study

Original title
Role of bromocriptine and pyridoxine in premenstrual tension syndrome
Authors
Sharma P, Kulshreshtha S, Singh GM et al.
Journal
Indian journal of physiology and pharmacology
Year
2007
Study design
Randomised trial
Participants
20
What was tested
Bromocriptine 2.5 mg twice daily, pyridoxine 100 mg/day, or placebo (ferrous sulphate 100 mg daily) for 3 months

Topics